Why Gilead Could Take Out Juno But Face Major Competition From This Biotech Giant Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Mark Terry… Source: BioSpace You Might Also Like Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline November 13, 2017 Stryker Takes Out Novadaq Corp. in $701 Million Deal June 19, 2017 Why This Massachusetts Synthetic Bio Startup Could be the Next Biotech Unicorn December 11, 2017
